Evaluation of nalidixic acid susceptibility testing for screening ofclinical strains of Salmonella with decreased susceptibility to ciprofloxacin

Iranshahi, Negin; Ranjbar, Reza; Siadat, Seyed Davar; Nejati, Mahdi; Harzandi, Naser; Norozian, Dariush; Naghoni, Ali; Morovvati, Said; Safiri, Zahra; Yousefi, Soheila; Tabaraie, Bahman

year 2, Issue 3 And 4 (3-2009) Iran J Med Microbiol 2009, 2(3 And 4): 39-45 | Back to browse issues page

Mendeley

Zotero

RefWorks

Iranshahi N, Ranjbar R, Siadat S D, Nejati M, Harzandi N, Norozian D, et al . Evaluation of nalidixic acid susceptibility testing for screening ofclinical strains of Salmonella with decreased susceptibility to ciprofloxacin. Iran J Med Microbiol 2009; 2 (3 and 4) :39-45
URL: http://ijmm.ir/article-1-127-en.html

Evaluation of nalidixic acid susceptibility testing for screening ofclinical strains of Salmonella with decreased susceptibility to ciprofloxacin

Negin Iranshahi¹

, Reza Ranjbar²

, Seyed Davar Siadat³

, Mahdi Nejati³

, Naser Harzandi¹

, Dariush Norozian³

, Ali Naghoni¹

, Said Morovvati²

, Zahra Safiri²

, Soheila Yousefi²

, Bahman Tabaraie⁴

1- Department of Microbiology, Islamic Azad University-Karaj Branch, Iran
2- Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
3- Bacterial vaccine and antigen preparation unit, Research and Production Complex, Pasteur Institute of Iran
4- Bacterial vaccine and antigen preparation unit, Research and Production Complex, Pasteur Institute of Iran , tabaraie@kfg.ir

Abstract: (16660 Views)

Background and objectives: Fluoroquinolones, in particular ciprofloxacin have recently become the drug of choice for antibiotic therapy of invasive Salmonella infections in many countries. however, several treatment failures due to Salmonella strains with decreased susceptibility to ciprofloxacin have been reported. These isolates are still considered to be susceptible to ciprofloxacin according to CLSI interpretive criteria (MIC≤1 µg/ml) while they can not be detected by disk diffusion test. CLSI has recommended nalidixic acid disk diffusion as an indicator test for screening of Salmonella isolates with decreased susceptibility to ciprofloxacin. In this study the value of nalidixic acid susceptibility testing for screening ofclinical strains of Salmonella with decreased susceptibility to ciprofloxacin was evaluated.
Material and methods: Salmonella spp. strains have been isolated from several provinces in Iran during 2007- 2008. The strains were identified by standard biochemical tests and serology. The susceptibility of the isolates to nalidixic acid and ciprofloxacin was determined by disk diffusion method. MIC assay for ciprofloxacin was determined by E. test.
Results: 28 out of 53 Salmonella strains (52.8%) were resistant to nalidixic acid. Disk diffusion testing showed that all isolates were susceptible to ciprofloxacin however 8 (15%) resistant nalidixic acid isolates showed decreased susceptibility to ciprofloxacin (MIC= 0.125 µg/ml) when tested by E.test.
Conclusion:The results showed that nalidixic acid disk diffusion test can be considered as a reliable and costeffective method for screening of Salmonella strains with low level resistance to ciprofloxacin.

Keywords: Salmonella, Ciprofloxacin, Nalidixic acid, Antibiotic susceptibility testing

Full-Text [PDF 229 kb] (2659 Downloads)

Type of Study: Original Research Article | Subject: Molecular Epidemiology
Received: 2013/11/16 | Accepted: 2013/11/16 | ePublished: 2013/11/16